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This doctoral thesis is focused on search for novel pyrazinamide derivatives with 
potential antitubercular activity. The theoretical part summarizes issues connected with 
tuberculosis and its epidemiological situation along with factors (resistance and HIV co-
infection) that complicate treatment of tuberculosis. A brief overview of antitubercular drugs 
used in current therapeutic regimens of tuberculosis is outlined. A single chapter is dedicated 
to pyrazinamide, which belongs to the first-line antitubercular drugs, and its possible 
mechanisms of action. The last part is focused on potential enzymatic targets of pyrazinamide 
derivatives.  
The practical part describes synthesis and biological evaluation of 112 pyrazinamide 
derivatives with modifications in amide moiety and position 3 on the pyrazine ring. First two 
series were derived from N-substituted 3-chloropyrazine-2-carboxamides, the third series 
contains 3-(phenylcarbamoyl)pyrazine-2-carboxylic acids and their esters, and the fourth series 
consists of N-substituted 3-aminopyrazine-2-carboxamides. Prepared compounds were in vitro 
screened for activity against four mycobacterial strains, namely Mycobacterium tuberculosis 
H37Rv, M. kansasii, M. avium and fast growing M. smegmatis. One compound, 3((4-
nitrophenyl)carbamoyl)pyrazine-2-carboxylic acid (series 3), exerted an excellent 
antimycobacterial activity against M. tuberculosis (MIC = 1.25 µg/mL; 5 µM). Frequent 
activity was ranged between 12.5 and 25 µg/mL. The structure-activity relationships were 
discussed. 
All compounds were additionally tested for their antibacterial and antifungal activity. 
Several compounds, especially from series N-benzyl-3-(benzylamino)pyrazine-2-
carboxamides and 3-amino-N-phenylpyrazin-2-carboxamides, exerted high antibacterial 
activity against staphylococcal strains including methicillin-resistant Staphylococcus aureus 
(MIC = 1.95–15.62 µM). 3-Amino-N-(4-ethylphenyl)pyrazine-2-carboxamide showed high 
antifungal activity (MIC = 7.81 µM) against Candida albicans. Some compounds were also 
tested for their antiviral and herbicidal activity with no observed effect. 
Selected compounds were studied using in silico docking methods to propose a possible 
enzymatic target. Used enzymes were enoyl-ACP reductase, which is involved in biosynthesis 
of mycolic acids, and decaprenylphosphoryl-β-D-ribose oxidase, which is an essential enzyme 
in arabinogalactan biosynthesis.  
 
